Study for HFpEF using heart pressure and energy signals
Treatments studied
Part of Heart & circulation clinical trials.
This Phase 2 study tests how matching heart “filling pressure” and heart muscle “energy use” may improve understanding or treatment of HFpEF, a type of heart failure with preserved pumping strength. You may be asked to have heart scans/tests and follow a study plan if your symptoms and test results fit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart failure symptoms that are stable and fall in NYHA class II to III
- Your left heart pumping strength (ejection fraction) is usually 50% or higher
- You’ve had signs of high filling pressure in the past, based on heart ultrasound, prior invasive measurements, or a recent acute episode needing IV diuretics
- You can safely do exercise testing (or similar study demands) and are willing to participate
- Your heart rhythm and blood work are in safe ranges (for example, no uncontrolled fast atrial fibrillation; hemoglobin at least 10)
- You do not have certain other heart, lung, liver, kidney, or blood conditions that could interfere with study safety
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether two medicines—an SGLT2 inhibitor and potassium nitrate—can improve symptoms and heart function in people with heart failure with preserved ejection fraction (HFpEF). It focuses on people who still have signs of “stiff” or high filling pressure in the heart despite a normal-ish ejection fraction.
This study looks at how the heart muscle works in people with a type of heart failure where the heart pumps normally but doesn't fill properly. It aims to understand the cause better, which could lead to new treatments.
This study looks at a type of heart failure where the heart pumps normally but is too stiff to fill properly. It aims to better understand and classify this condition, which may help guide future treatments.
This trial tests whether a structured exercise training program can improve symptoms and quality of life in people with heart failure with preserved ejection fraction (HFpEF), a condition where the heart pumps normally but is too stiff to fill properly. Participants will receive exercise training alongside their usual heart failure medications.
This early-phase trial tests a treatment that aims to improve the “natriuretic peptide” hormone system in people with HFpEF (heart failure with preserved pumping strength). It may help reduce symptoms and improve heart and fluid pressure behavior, especially in certain related conditions like kidney disease.
This study tests a new drug called finerenone to see if it can improve heart function in people with a type of heart failure where the heart pumps normally but is stiff. It may help reduce symptoms and improve quality of life.
Hear when a new Heart Failure With Preserved Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.